The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis
- Creator: Yam, Charmaine , Merlo, Daniel , Stankovich, Jim , Darby, David , Gresle, Melissa , Kalincik, Tomas , Kilpatrick, Trevor J. , Lechner-Scott, Jeanette , Taylor, Bruce , Barnett, Michael , Butzkueven, Helmut , van der Walt, Anneke
- Resource Type: journal article
- Date: 2020
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis
- Creator: Yan, Jun , Liu, Jia , Mason, Deborah , Griffiths, Lyn , Moscato, Pablo , Slee, Mark , Taylor, Bruce , Wiley, James , Field, Judith , Butzkueven, Helmut , Kilpatrick, Trevor J. , Csurhes, Peter A. , Lin, Clement Yihao , Pender, Michael P. , McCombe, Pamela A. , Greer, Judith M. , Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZGene), , Scott, Rodney J. , Lechner-Scott, Jeannette , Brown, Matthew A. , Booth, David R. , Stewart, Graeme J. , Broadley, Simon
- Resource Type: journal article
- Date: 2012
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination
- Creator: Zarghami, Amin , van der Mei, Ingrid , Taylor, Bruce V. , AusLong Investigator Group, , Hussain, Mohammad Akhtar , Claflin, Suzi B. , Bessing, Barnabas , Simpson-Yap, Steve , Ponsonby, Anne-Louise , Lechner-Scott, Jeanette , Broadley, Simon , Blizzard, Leigh
- Resource Type: journal article
- Date: 2022
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
- Creator: Zhu, Chao , Zhou, Zhen , Roos, Izanne , Merlo, Daniel , Kalincik, Tomas , Ozakbas, Serkan , Skibina, Olga , Kuhle, Jens , Hodgkinson, Suzanne , Boz, Cavit , Alroughani, Raed , Lechner-Scott, Jeannette , Barnett, Michael , Izquierdo, Guillermo , Prat, Alexandre , Horakova, Dana , Havrdova, Eva Kubala , Macdonell, Richard , Patti, Francesco , Khoury, Samia Joseph
- Resource Type: journal article
- Date: 2022
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation
- Creator: Zhu, Chao , Kalincik, Tomas , Patti, Francesco , Grand'Maison, Francois , Hodgkinson, Suzanne , Grammond, Pierre , Lechner-Scott, Jeannette , Butler, Ernest , Prat, Alexandre , Girard, Marc , Duquette, Pierre , Macdonell, Richard A. L. , Horakova, Dana , Weinstock-Guttman, B , Ozakbas, S , Slee, M , Sa, MJ , Van Pesch, V , Barnett, M , Van Wijmeersch, B , Gerlach, O , Prevost, J , Terzi, M , Zhou, Zhen , Boz, C , Laureys, G , Van Hijfte, L , Kermode, AG , Garber, J , Yamout, B , Khoury, SJ , Merlo, D , Monif, M , Jokubaitis, V , Buzzard, Katherine , van der Walt, A , Butzkueven, H , MSBase, SG , Skibina, Olga , Alroughani, Raed , Izquierdo, Guillermo , Eichau, Sara , Kuhle, Jens
- Resource Type: journal article
- Date: 2023